Basics Guardant Health, Inc. IPO Date: October 1, 2018 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $8.75B Activated in VL: True Average Daily Range Avg Daily Range: $1.68 | 2.78% Avg Daily Range (30 D): $1.20 | 1.92% Avg Daily Range (90 D): $1.08 | 1.97% Institutional Daily Volume Avg Daily Volume: 1.29M Avg Daily Volume (30 D): 1.95M Avg Daily Volume (90 D): 2.04M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 7,661 Avg Inst. Trade: $3.1M Avg Inst. Trade (30 D): $3.6M Avg Inst. Trade (90 D): $3.49M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $6.66M Avg Closing Trade (30 D): $15.75M Avg Closing Trade (90 D): $15.14M Avg Closing Volume: 132.65K     News Oct 22, 2025 @ 6:26 PM Molecular Diagnostics Market to Grow at 13.1% CAGR... Source: Bcc Research Aug 22, 2025 @ 1:00 PM Global Liquid Biopsy Market Set to Reach USD 7.05 ... Source: Marketsandmarkets Jul 31, 2025 @ 9:06 AM Guardant Health (GH) Q2 Revenue Up 31% Source: Jesterai Jul 25, 2025 @ 8:55 AM Minimal Residual Disease Testing Market Trends Ana... Source: Researchandmarkets.Com Jun 12, 2025 @ 8:58 AM Molecular Diagnostics for Cancer Market Research 2... Source: Researchandmarkets.Com Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.8 $-.77 $-.9 Diluted EPS $-.8 $-.77 $-.9 Revenue $ 232.09M $ 203.47M $ 201.81M Gross Profit $ 150.88M $ 128.75M $ Net Income / Loss $ -99.9M $ -95.16M $ -111.01M Operating Income / Loss $ -106.41M $ -111.04M $ -125.97M Cost of Revenue $ 81.21M $ 74.72M $ Net Cash Flow $ -68.37M $ 174.1M $ -56.84M PE Ratio